Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS-related Kaposi Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00427414
What this trial is testing

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 14
Not applicableStudy completedNCT00339326
What this trial is testing

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Who this might be right for
Kaposi's Sarcoma
National Cancer Institute (NCI) 1,383
Testing effectiveness (Phase 2)WithdrawnNCT00521092
What this trial is testing

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

Who this might be right for
AIDS-related Kaposi SarcomaClassic Kaposi Sarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00020449
What this trial is testing

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00001059
What this trial is testing

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Ended earlyNCT00006222
What this trial is testing

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00450320
What this trial is testing

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 7
Not applicableLooking for participantsNCT00006518
What this trial is testing

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Who this might be right for
HIVKaposi's SarcomaLymphomas+2 more
National Cancer Institute (NCI) 1,029
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00090987
What this trial is testing

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 30
Post-approval studies (Phase 4)Study completedNCT00444379
What this trial is testing

Anti-Retrovirals for Kaposi's Sarcoma

Who this might be right for
Kaposi's SarcomaHIV Infections
University of California, San Francisco 224
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01752569
What this trial is testing

Selumetinib in Patients With Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi's Sarcoma
Sheffield Teaching Hospitals NHS Foundation Trust 19
Large-scale testing (Phase 3)Study completedNCT00002319
What this trial is testing

DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Sequus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00000807
What this trial is testing

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 41
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00019188
What this trial is testing

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Epidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00000660
What this trial is testing

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00019123
What this trial is testing

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Next Page